Effect of Pitavastatin on lipid-lowering, and Lipid-rich Carotid Plaques and in patients with dyslipidemia Using carotid ultrasound: A Prospective, Multicenter Study

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800017776

Enrollment

Unknown

Registered

2018-08-14

Start date

2018-08-08

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mixed dyslipidemia Primary hypercholesterolemia

Interventions

Group 1:Pivastatin 2mg

Group 2:Pivastatin 4mg

Combined treatment group:Pivastatin4mg and Ezetimibe10mg

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Mixed dyslipidemia; 2. Primary hypercholesterolemia; 3. ultrasound images taken in the carotid arteries show the presence of atherosclerotic plaque, and the smallest visible plaque longitudinal section IMT ? 1.5 mm; 4. Other protocol-defined inclusion criteria may apply.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or lactating, or planning to become pregnant; 2. Subject's NYHA cardiac function level 4, can not be supine for more than 24 hours; 3. Other protocol-defined exclusion criteria may apply.

Design outcomes

Primary

Measure	Time frame
LDL-C;Carotid plaque;	—

Countries

China

Contacts

Public ContactXinchun Yang, Chunlin Yin

Beijing Chao-Yang Hospital, Capital Medical University

yxc6229@sina.com+86 13701186229

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026